Research in brief

The prevalence of the new orthonairovirus, named the Wetland virus, was subsequently tracked by researchers in north-eastern China using active hospital surveillance and molecular and serological testing. RSV vaccine effectiveness The US Centers for Disease Control and Prevention recommends respirat...

Full description

Saved in:
Bibliographic Details
Published in:The Lancet infectious diseases 2024-10, Vol.24 (10), p.e626-e626
Main Author: Venkatesan, Priya
Format: Article
Language:English
Subjects:
Antibiotics
Coronaviruses
Disease control
Disease transmission
Effectiveness
Health services
Immunization
Infections
Medical research
Mpox
Respiratory syncytial virus
Respiratory tract
Respiratory tract diseases
Vaccine efficacy
Vaccines
Viruses
Wetlands
Zoonoses
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The prevalence of the new orthonairovirus, named the Wetland virus, was subsequently tracked by researchers in north-eastern China using active hospital surveillance and molecular and serological testing. RSV vaccine effectiveness The US Centers for Disease Control and Prevention recommends respiratory syncytial virus (RSV) vaccination for adults aged 60 years and older, based on its efficacy against lower respiratory tract disease in pre-licensure trials. All individuals with an indication for testing should be offered effective treatment if confirmed to have active infection and undergo a test of cure after treatment.
ISSN:1473-3099
1474-4457
DOI:10.1016/S1473-3099(24)00613-3